Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: Rapid dFLC Response Predict CHR in AL Amyloidosis

View source ↗

Summary

Clinical trial investigating whether a rapid dFLC response can predict complete hematologic response in systemic AL amyloidosis. The study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Peking University People's Hospital | Conditions: Systemic AL Amyloidosis | Status: RECRUITING